Author
Li Qiu
Recent research
- Materials & Energy
Abstract Fe3O4, the first reported nanozyme and the first FDA-approved transition-metal-based nanomaterial, holds promise for antibacterial therapy but is limited by poor ROS catalytic activity and utilization. Inspired by macrophage-like bacterial capture and insect wing micro/n...
- Engineering & Technology
Overcoming Biological Barriers with Sononanomedicine: New Horizons in Oncology and Neurology
Abstract Biological barriers, including the tumor microenvironment and the blood–brain barrier, represent the primary bottleneck for the clinical translation of nanomedicines in oncology and neurology. Ultrasound, characterized by noninvasiveness, deep tissue penetration, and hig...